Improving Sleep for Chronic Pain
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores two methods to assist individuals who struggle with sleep due to chronic pain and use opioids for pain management. One group will participate in an online program called CBT-I (Cognitive Behavioral Therapy for Insomnia), which includes weekly sessions to enhance sleep over eight weeks. The other group will continue their usual sleep and pain care. This trial suits those who have used opioid medication regularly for over a month, experience chronic pain and insomnia, and wish to reduce or stop opioid use. As an unphased trial, it offers a unique opportunity to explore new methods for improving sleep and reducing opioid use.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it allows medications prescribed for pain or sleep. You should have a written agreement from your doctor if you are on opioid medication.
What prior data suggests that these behavioral interventions are safe for individuals with chronic pain?
A previous study demonstrated that cognitive behavioral therapy for insomnia (CBT-I) is safe and effective. Research suggests it improves sleep for individuals with both insomnia and chronic pain. Participants typically find CBT-I manageable, with few negative side effects reported. Studies also show that online or app-based versions of CBT-I are as effective and safe as in-person sessions. This makes CBT-I a reliable choice for improving sleep without added risk.12345
Why are researchers excited about this trial?
Researchers are excited about using Cognitive Behavioral Therapy for Insomnia (CBT-I) to improve sleep in individuals with chronic pain because it offers a new approach compared to traditional treatments like medication. Unlike medications that often focus on symptom relief, CBT-I aims to tackle the root causes of sleep issues by changing sleep habits and thought patterns. This therapy is delivered online, making it accessible and convenient for patients, removing barriers like travel and scheduling conflicts. Additionally, CBT-I is non-pharmacological, reducing the risk of side effects and dependency associated with sleep medications.
What evidence suggests that CBT-I is effective for improving sleep in individuals with chronic pain?
Research has shown that Cognitive Behavioral Therapy for Insomnia (CBT-I) improves sleep quality. Studies have found that CBT-I makes falling asleep easier and enhances overall sleep patterns. One study discovered that CBT-I works as well as sleep medication but with fewer side effects and longer-lasting benefits. Additionally, CBT-I has been shown to reduce insomnia and improve sleep quality for people with chronic pain. In this trial, participants will receive either 8 weeks of online CBT-I or continue with their standard treatment for sleep and pain. These findings suggest that CBT-I could be a promising treatment for those with both long-term insomnia and chronic pain.46789
Who Is on the Research Team?
Britani Holland, PhD
Principal Investigator
University of South Florida
Christina S McCrae, PhD
Principal Investigator
University of South Florida
Are You a Good Fit for This Trial?
This trial is for people who have chronic pain and insomnia, and are currently using prescribed opioids. It aims to help them sleep better and reduce their opioid use.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive 8 weeks of online CBT-I (1 session/week for 1 hour), followed by tapered withdrawal and motivational interviewing and check-ins
Tapered Withdrawal
Participants undergo a gradual tapering of opioid medication with motivational interviewing and check-ins
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessments at 6 months
What Are the Treatments Tested in This Trial?
Interventions
- CBT-I
CBT-I is already approved in United States, European Union, Canada for the following indications:
- Chronic insomnia
- Insomnia in individuals with chronic pain
- Insomnia in individuals with psychiatric comorbidities
- Chronic insomnia
- Insomnia in individuals with chronic pain
- Insomnia in individuals with psychiatric comorbidities
- Chronic insomnia
- Insomnia in individuals with chronic pain
- Insomnia in individuals with psychiatric comorbidities
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of South Florida
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Collaborator
National Institutes of Health (NIH)
Collaborator